Mabworks is based in Beijing, China. It has raised $333M in total funding. Latest round: Series C.
Mabworks funding overview
Mabworks is based in Beijing, China. Mabworks has raised $333M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in April 2020. The round record for Mabworks runs through 2020; nothing later has been disclosed. Investors on record include CICC Qide Innovative Biopharmaceutical Equity Investment Fu…, Citic Securities, Lyzz Capital, Huge Capital, Beijing E-Town Biomedical Park, Bocom International and 3 others. 9 distinct backers are named across the disclosed rounds.
Mabworks has raised $333M in total disclosed funding across the rounds on record.
Who has invested in Mabworks?
CICC Qide Innovative Biopharmaceutical Equity Investment Fu…, Citic Securities, Lyzz Capital, Huge Capital, Beijing E-Town Biomedical Park, Bocom International are named among the investors backing Mabworks.
What was the latest Mabworks funding round?
The most recent disclosed round is a Series C, announced in April 2020.
Where is Mabworks based?
Mabworks is based in Beijing, China.
When did Mabworks last raise?
The last disclosed Mabworks round closed in April 2020 at Series C.
Mabworks totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Beijing below to benchmark round size and investor mix.
